First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-04-14 15:46:13Open Document File Size: 499,21 KBShare Result on FacebookCityLiverpool / Salaam / Blantyre / White / Cambridge / Basel / /CompanyNovartis Pharma AG / Creative Commons / Population Approach Group Europe / /ContinentAfrica / North America / Europe / /CountrySwitzerland / Sweden / South Africa / New Zealand / Zimbabwe / Thailand / United States / Malawi / Brazil / Tanzania / China / / /FacilityInstitute of Infectious Disease / University of Liverpool / University of Cape Town / University of Auckland / University of Health / /IndustryTermTherapies for most of the diseases / pharmaceutical industry / healthcare / pharmaceutical / keyword search / healthcare workers / healthcare environment / treatment of HIV / computing / advance online publication / healthcare outcome / /MedicalConditionTB / local diseases / HIV / non-communicable diseases / falciparum malaria / Chagas disease / malnutrition / disease / several neglected infectious diseases / malaria / diseases / highest disease / infectious diseases / HIV/AIDS / infection / human African trypanosomiasis / tuberculosis / /MedicalTreatmentcombination drug therapy / pharmacotherapy / /Organization5Muhimbili University of Health and Allied Sciences / World Health Organization / University of Liverpool / University of Auckland / Auckland / Department of Medicine / FDA / University of Cape Town / Cape Town / Institute of Infectious Disease and Molecular Medicine / /PersonKathleen Sprangers / Thomas Bouillon / Michael Looby / Stephen Moore / /Positionadvocate / /Productefavirenz / mefloquine / nevirapine / Stavudine / /ProvinceOrStateNew Jersey / Massachusetts / /RegionWestern Europe / /Technologyanti-infectives / Pharmacokinetics / drug discovery / distance learning / drug design / Simulation / drug development / /URLhttp /SocialTag |